Published Date: 07 May 2025
Telling the difference between benign and cancerous thyroid nodules before surgery is notoriously challenging, but a new study finds that a combination of artificial intelligence and data analysis techniques may yield surprisingly ...
Read Full News1.
Combo of Approved Agents Active in High-Risk Large B-Cell Lymphoma
2.
Cancer detection recovered following pandemic disruptions
3.
Research indicates that extended PSMA therapy is safe and effective for patients with prostate cancer.
4.
Prostate cancer, rectal exams, Casgevy approved for thalassemia, and two million cancer cases.
5.
Survivors of childhood brain cancer are more likely to be held back in school
1.
The Statistical Frontier of Hematology Oncology: Diagnostics, Therapies, and Future Horizons in Hematology Oncology 2025
2.
Everything You Need To Know About Splenic Infarction – Symptoms, Treatments, And Prevention
3.
Emerging Therapies Using Immune-Reshaping Tumor Microenvironment Technologies
4.
Building Bridges between Heart and Cancer Care: A Comprehensive Guide to Cardio-Oncology Clinics
5.
How Digital Innovation and AI-Powered Case Studies are Revolutionizing Oncology Education?
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Latest Advances in Hematology
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI
4.
Navigating the Complexities of Ph Negative ALL - Part XIII
5.
Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Lenalidomide and Dexamethasone (Rd) in MRD Negativity
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation